M&A Deal Summary |
|
|---|---|
| Date | 2017-08-23 |
| Target | ChromaDex - Analytical Testing Services |
| Sector | Test/Measurement Equipment |
| Buyer(s) | LabCorp |
| Sellers(s) | Niagen Bioscience |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1995 |
| Sector | Test/Measurement Equipment |
| Employees | 67,000 |
| Revenue | 13.0B USD (2024) |
LabCorp of America Holdings is a provider of medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. LabCorp was founded in 1995 and is based in Burlington, North Carolina.
| DEAL STATS | # |
|---|---|
| Overall | 34 of 46 |
| Sector: Test/Measurement Equipment M&A | 3 of 5 |
| Type: Divestiture M&A Deals | 10 of 16 |
| State: California M&A | 7 of 9 |
| Country: United States M&A | 32 of 44 |
| Year: 2017 M&A | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-07-31 |
Chiltern International
Bristol, Tennessee, United States Chiltern International, Inc. is a global contract research organization, and a provider of clinical services and solutions in a variety of therapeutic areas with engagement models for biopharmaceutical and medical device industries. Chiltern’s team of more than 4,500, located across 47 countries, provides comprehensive Clinical Development, Medical & Scientific Affairs, Data & Analysis, Pharmacovigilance and Strategic Regulatory services using a collaborative approach for more efficient clinical trials. Visit Chiltern.com to learn more about how Chiltern is Designed Around You®. |
Buy | $1.2B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-06-11 |
Sciformix
Westborough, Massachusetts, United States Sciformix Corp. is a scientific process outsourcing company focused on pharmacovigilance and regulatory solutions for biopharmaceutical and medical devices clients. Sciformix is based in Westborough, Massachusetts. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1999 |
| Sector | Life Science |
| Employees | 104 |
| Revenue | 100M USD (2024) |
Niagen Bioscience is a provider in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. The company works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to everyday lifestyle stressors. NAD+ depletion is a key contributor to age-related changes in health and vitality. Niagen Bioscience was founded in 1999 and is based in Los Angeles, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Test/Measurement Equipment M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2017 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-03-29 |
NeutriSci International - BluScience
Calgary, Alberta, Canada NeutriSci International, Inc.'s BluScience is a provider of consumer product line of dietary supplements. |
Buy | $6M |
